By Elise Czajkowski ( September 3, 2009, 5:55 PM EDT) -- Dainippon Sumitomo Pharma Co. Ltd. said Thursday that it would acquire Sepracor Inc. for $2.6 billion, in a move that will boost the Japanese company's U.S. presence and expand its pharmaceutical portfolio to include such drugs as the blockbuster anti-insomnia pill Lunesta....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.